BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6438244)

  • 21. Cost analysis of an innovative eHealth program in Nigeria: a case study of the vaccine direct delivery system.
    Sato R; Metiboba L; Galadanchi JA; Adeniran MF; Hassan SH; Akpan D; Odogwu J; Fashoto B
    BMC Public Health; 2023 Sep; 23(1):1691. PubMed ID: 37658292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OUTBREAK OF CEREBROSPINAL MENINGITIS IN KEBBI STATE, NIGERIA.
    Gana GJ; Badung S; Bunza AU; Gidado S; Nguku P
    Ann Ib Postgrad Med; 2017 Jun; 15(1):23-28. PubMed ID: 28970767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nigeria rolls out novel meningitis vaccine.
    Ashinze P; Mafua N; Obafemi E
    Lancet; 2024 Jun; 403(10442):2373. PubMed ID: 38823982
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimal control and cost-effective analysis of the 2017 meningitis outbreak in Nigeria.
    Agusto FB; Leite MCA
    Infect Dis Model; 2019; 4():161-187. PubMed ID: 31193915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of a Neisseria meningitidis case: factors that guarantee the effectiveness of supporting Public Health actions.
    Voltolini A; Marcotrigiano V; Cian S; Fiorito N; Sollano A; Dall'O I; Battistin M; Bino E; Lovat A; D'IncĂ  P; Baldovin T; Baldo V; Cinquetti S
    Ann Ig; 2024 May; ():. PubMed ID: 38717345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum to "Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana" [Vaccine 37(37) (2019) 5657-5663].
    Cooper LV; Stuart JM; Okot C; Asiedu-Bekoe F; Afreh OK; Fernandez K; Ronveaux O; Trotter CL
    Vaccine; 2023 Nov; 41(49):7491-7492. PubMed ID: 37945491
    [No Abstract]   [Full Text] [Related]  

  • 27. Meningococcal Meningitis.
    Johri S; Gorthi SP; Anand AC
    Med J Armed Forces India; 2005 Oct; 61(4):369-74. PubMed ID: 27407812
    [No Abstract]   [Full Text] [Related]  

  • 28. Quagmire of epidemic disease outbreaks reporting in Nigeria.
    Omoleke SA; Ajibola O; Ajiboye JO; Raji RO
    BMJ Glob Health; 2018; 3(1):e000659. PubMed ID: 29527352
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
    Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG
    PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
    Mohammed I; Iliyasu G; Habib AG
    Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approaches to prevent acute bacterial meningitis in developing countries.
    Wright PF
    Bull World Health Organ; 1989; 67(5):479-86. PubMed ID: 2611973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of meningococcal infection in the African meningitis belt by selective vaccination.
    Greenwood BM; Wali SS
    Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.
    Robbins JB; Towne DW; Gotschlich EC; Schneerson R
    Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis.
    Greenwood BM
    Rev Infect Dis; 1984; 6(3):374-89. PubMed ID: 6429812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
    Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
    J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.